Workplan
The project work plan will be made up of 4 work packages.
The objective of the first 3 is to identify the footprint of COVID19, the mixture of volatile compounds that are emitted in respiration that identify COVID19.
The 4 is to bring the PMV to a commercial product.
Subsequently, development will continue to achieve devices that detect any disease, generating a new line of business for odor medicine "Breathonics as service".
The first work package (Hardware) is the most critical. Because it is necessary to select a series of sensors that have the ability to identify the footprint of COVID19.
To select them we will proceed through the following process:
- Carrying out a spectrometric analysis of the air of a sick person from COVID19
- The comparison between the previously obtained result and those known, through scientific bibliography, of related diseases.
In this way there would be a list of potential compounds that would have to be acquired by the appropriate sensors and incorporated into the hardware.
The next step would be to check that this hardware works, being carried out among a certain number of volunteers, who spend their illness at home.
The hardware will have a “friendly” application that will serve as an interface between the electronic board and the user, allowing the indication of their health status and the sending of information to a database.
If it is verified that everything works correctly and detects, a greater number of volunteers would be passed on to obtain relevant data.
All the data will be concentrated in a database, where different artificial intelligence algorithms will be applied to detect the COVID19 footprint.
Once the fingerprint (the combination of volatile compounds that are emitted when breathing and that identifies COVID19) has been detected, it is possible to continue with the development to transform this PMV to a commercial class IIA medical device.
In later phases, development will continue to commercialize medical devices with the capacity to detect any present and future disease, generating a new line of business in SMASP on odor medicine that will be called “Breathonics as service”
The different work packages are detailed below.
|
|
WORK PACKAGE: HARDWARE. (H) |
|||||
|
Name |
Alberto Arenillas |
Celestine Preetham |
Divyesh Khamele |
Alejandro Martin Ana Monteverdi |
|
|
|
Role |
Coordinator |
Artificial intelligence |
Electronic design |
Medicine |
|
|
|
Description: Design, development and manufacture of electronic equipment to detect organic compounds in respiration.
|
||||||
|
WORK PLAN: 4 months
|
||||||
|
SENSORS (S)
|
||||||
|
Identification of VOCs / NCOVs that could potentially be part of the COVID19 footprint (spectrography and comparison) |
||||||
|
TASK H-S2: SELECTION OF SENSORS |
||||||
|
Selection of appropriate sensors to detect potential VOCs / NCOVs |
||||||
|
ELECTRONIC DEVICE (DE) |
||||||
|
Electronic design, controller selection and components |
||||||
|
TASK H-DE2: DEVICE MOUNTING |
||||||
|
Purchase and implementation of components |
||||||
|
SENSOR ARRAY (AS) |
||||||
|
TASK H-AS1: SENSOR IMPLEMENTATION |
||||||
|
Implementation of the different sensors on a breadboard |
||||||
|
TASK H-AS-2: ARRAY ARTIFICIAL INTELLIGENCE |
||||||
|
Application of artificial intelligence algorithms to increase detection from Ppm to Ppb |
||||||
|
VALIDATION AND TUNING (PP) |
||||||
|
TASK H-PP1: VERIFICATION OPERATION |
||||||
|
Function check |
||||||
|
|
WORK PACKAGE: INFORMATION MANAGEMENT (GI) |
|||||
|
Name |
Alberto Arenillas |
Celestine Preetham |
Divyesh Khamele |
Alejandro Martin |
Anna Valli |
|
|
Role |
Coordinator |
Artificial intelligence |
Electronic design |
Emergency Medicine |
Strategy |
|
|
Description: Creation of the volunteer database, information sharing, creation of the database and applications to manage the information.
|
||||||
|
WORK PLAN: 2 months
|
||||||
|
CREATION PROJECT WEBSITE (W)
|
||||||
|
TASK GI-W1: DESIGN AND IMPLEMENTATION WEB PAGE |
||||||
|
Development of a project website so that volunteers can interact with it and receive information |
||||||
|
VOLUNTEERS (V) |
||||||
|
TASK GI-V1: VOLUNTEER DATABASE GENERATION |
||||||
|
Creation of a database of volunteers, linked to the project's website |
||||||
|
TASK GI-V2: DISSEMINATION INFORMATION |
||||||
|
Dissemination of the project through contacts, social networks and other means |
||||||
|
TASK GI-BD1: DESIGN OF A CENTRAL DATABASE |
||||||
|
Creation of a centralized database where all the data sent by the volunteers' electronic devices will be collected. |
||||||
|
APPLICATIONS FOR INFORMATION MANAGEMENT (AGI) |
||||||
|
TASK GI-AGI1: DEVELOPMENT OF A MOBILE APPLICATION FOR MANAGEMENT OF THE ELECTRONIC DEVICE |
||||||
|
Development of a mobile application so that volunteers can interact with the mobile device and send information to the central database |
||||||
|
VALIDATION AND TUNING (PP) |
||||||
|
TASK GI-PP1: VERIFICATION OPERATION |
||||||
|
Checking operation of all the above. |
||||||
|
|
WORK PACKAGE: THE AROMA OF COVID19 (AR) |
|||||
|
Name |
Alberto Arenillas |
Celestine Preetham |
Divyesh Khamele |
Alejandro Martin Anita Monteverdi |
Anna Valli Igor Rogelj Alberto Arenillas |
|
|
Role |
Coordinator |
Artificial intelligence |
Electronic design |
Medicine |
Strategy |
|
|
Identification of the mixture of volatile components that define the “footprint” of COVID19
|
||||||
|
WORK PLAN: 6 months
|
||||||
|
ARTIFICIAL INTELLIGENCE FOOTPRINT DETERMINATION (IA)
|
||||||
|
Generation of specifications for the creation of the contest and dissemination of information, |
||||||
|
TASK AR-IA2: KAGGLE COMPETITION |
||||||
|
Creation and monitoring of the Kaggle contest |
||||||
|
TASK AR-IA3: ALGORITHM IMPLEMENTATION |
||||||
|
Implementation of the winning algorithm in the project |
||||||
|
ITERATION OF PREVIOUS PROCESSES (IT) |
||||||
|
TASK AR-IT1: SENSOR ITERATION |
||||||
|
Does not detect, it is necessary to select new sensors |
||||||
|
TASK AR-IT2: HARDWARE ITERATION |
||||||
|
Does not detect, it is necessary to select new hardware |
||||||
|
TASK AR-IT3: ARTIFICIAL INTELLIGENCE ITERATION |
||||||
|
Does not detect, it is necessary to modify the artificial intelligence algorithms |
||||||
|
FOOTPRINT DETERMINATION (HU) |
||||||
|
TASK AR-HU1: RESULTS OF THE ALGORITHMS OF AI, OBTAINING THE FOOTPRINT |
||||||
|
Positive validation, obtaining the “footprint” of COVID19 |
||||||
|
DEFINITIVE SENSORS SELECTION (SD) |
||||||
|
TASK AR-SD1: IMPLEMENTATION OF FINAL SENSORS |
||||||
|
Implantation of the definitive sensors in the electronic device to carry out massive pre-certification tests. |
||||||
|
VALIDATION AND TUNING (PP) |
||||||
|
TASK AR-PP1: OPERATION VERIFICATION |
||||||
|
Clinical verification of the operation of all the above. |
||||||
|
|
WORK PACKAGE: DEMONSTRATOR (DEMI) |
|||||
|
Name |
Alberto Arenillas |
Celestine Preetham Divyesh Khamele |
Estela Sánchez |
Alejandro Martin Anita Monteverdi |
Anna Valli Igor Rogelj Alberto Arenillas |
|
|
Role |
Coordinator |
Artificial intelligence |
Innovation |
Medicine |
Strategy |
|
|
Description: Design, development and manufacture of a product close to commercial. New functionalities (generic disease detection) are included in the final phase of this package. Development of a strategy of protection and transfer of results depending on the product obtained. |
||||||
|
WORK PLAN: 6 months
|
||||||
|
SPECIFICATIONS (ESP)
|
||||||
|
TASK DEMI-ESP1: GENERATION SPECIFICATIONS |
||||||
|
Specifications for the manufacture and purchase of components. |
||||||
|
DEVELOPMENT (DESA) |
||||||
|
TASK DEMI-DESA1: PROTOTYPE DESIGN |
||||||
|
Design of a prototype taking into account the homologation and certification process. |
||||||
|
Generation of documentation for CE approval and certification according to 93/42 / EEC type IIa |
||||||
|
TASK DEMI-DESA3: DEVELOPMENT OF A STRATEGY FOR PROTECTION OF RESULTS |
||||||
|
Generation of the industrial and / or intellectual protection strategy of the possible results in order to obtain the widest and most adequate protection possible and prospecting of the different exploitation scenarios of the aforementioned results. |
||||||
|
MANUFACTURE (FAB) |
||||||
|
TASK DEMI-FAB1: PROTOTYPE MANUFACTURE |
||||||
|
Manufacture of the functional prototype. |
||||||
|
STRATEGY AND DEVELOPMENT BUSINESS MODEL (EST) |
||||||
|
TASK DEMI-EST1: DEVELOPMENT OF A PROTOTYPE MARKETING PLAN |
||||||
|
Marketing strategy, marketing, |
||||||
|
Development of a transfer strategy for the products obtained |
||||||
|
VALIDATION, CERTIFICATION AND TUNING (PP) |
||||||
|
Validation of the clinical prototype. |
||||||
|
TASK DEMI-PP2: VALIDATION PROCESS AND SETTING UP |
||||||
|
Prototype operation validation. |
||||||
|
Prototype certification process in the European and American market. |
||||||
|
MARKETING (COM) |
||||||
|
TASK DEMI-COM1: IMPLEMENTATION OF MARKETING AND MARKETING PLAN |
||||||
|
Marketing, presentation at fairs, dissemination, writing technical articles. |
||||||
|
DEVELOPMENT OF NEW FUNCTIONALITIES AND PRODUCT (NF) |
||||||
|
New functionalities to detect any disease |
||||||
|
TASK DEMI-NF2: DEVELOPMENT OF NEW PRODUCTS |
||||||
|
Development of new products. |
||||||
